Sulbutiamine
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Sulbutiamine"
.

content
Sulbutiamine
Systematic (IUPAC) name
[4-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-formyl-
amino]-3-[2-[(4-amino-2-methyl-pyrimidin-5-yl)methyl-
formyl-amino]-5-(2-methylpropanoyloxy)pent-2-en-3-
yl]disulfanyl-pent-3-enyl] 2-methylpropanoate
Identifiers
CAS number 3286-46-2
ATC code A11DA02
PubChem 71124
Chemical data
Formula C32H46N8O6S2 
Mol. mass 702.89 g/mol
SMILES eMolecules & PubChem
Synonyms Arcalion, bisibuthiamine, youvitan
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 5 hours
Excretion Renal
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Oral

Sulbutiamine (brand name: Arcalion) is a precursor to thiamine (i.e., vitamin B1).

Contents

Uses

It is indicated for the treatment of asthenia.[1] Furthermore, the ability of sulbutiamine to reduce fatigue is considered desirable by athletes, and it is available for over-the-counter sale as a nutritional supplement. Additionally, the demonstrated ability of sulbutiamine to improve memory in rats[2] and patients of schizophrenia[2] suggests that it is a nootropic. New research show support for use in erectile dysfunction [3]


Effects

Sulbutiamine reduces fatigue, memory difficulties, intellectual tiredness and may speed convalescence.[4]


Dosage

Sulbutiamine is sometimes supplied in 200 mg tablets. The proper therapeutic dosage has been reported to be 12.5 mg/kg,[2] which corresponds to 850 mg for a 68 kg (150 lb) person. However, it should be noted that dosage recommendations vary; the manufacturer of Arcalion, for example, recommends no more than 600 mg per day.


Mechanisms of action

Sulbutiamine crosses the blood brain barrier more easily than vitamin B1 because of its lipophilic properties. It leads to an increased formation of thiamine triphosphate (TTP) that acts as a regulator of the synaptic transmission of many neurotransmission systems.

Sulbutiamine is a thiamine derivative which has two different properties in comparison with vitamin B1 as a result of structural modification of free thiamine, namely opening of the thiazole ring, esterification of the alcohol groups and dimerization, with formation of a disulfide bridge.

References

  1. ^ Shah SN; Sulbutiamine Study Group (2003). "Adjuvant role of vitamin B analogue (sulbutiamine) with anti-infective treatment in infection associated asthenia.". J Assoc Physicians India 51: 891–5. PMID 14710977. 
  2. ^ a b c Bizot JC, Herpin A, Pothion S, Pirot S, Trovero F, Ollat H (2005). "Chronic treatment with sulbutiamine improves memory in an object recognition task and reduces some amnesic effects of dizocilpine in a spatial delayed-non-match-to-sample task.". Prog Neuropsychopharmacol Biol Psychiatry 29 (6): 928–35. doi:10.1016/j.pnpbp.2005.04.035. PMID 15951087. 
  3. ^ Urologiia. 2005 Jan-Feb;(1):32-5. [Clinical efficacy of the drug enerion (sulbutiamine) in the treatment of patients with psychogenic (functional) erectile dysfunction] Dmitriev DG, Gamidov SI, Permiakova OV.
  4. ^ Serdia Pharmaceuticals | About Serdia | Product Portfolio | Arcalion

External links

© jGames.co.uk 2007 (some content from Wikipedia under GDL ) !-- ValueClick Media 468x60 and 728x90 Banner CODE for jgames.co.uk -->
Your Ad Here